Figure 4From: CD133 expression is not an independent prognostic factor in stage II and III colorectal cancer but may predict the better outcome in patients with adjuvant therapy Kaplan-Meier survival curves in the CD133- (<10% expression) colorectal cancer patients according to adjuvant therapy status. There was no statistically significant difference in OS according to the adjuvant therapy status (p=0.055).Back to article page